CorMedix Inc.
CRMD
$6.39
$0.020.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 617.03% | 1,647.68% | 14,970.64% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 617.03% | 1,647.68% | 14,970.64% | -- | -- |
| Cost of Revenue | 619.17% | 518.85% | 292.74% | 372.10% | -- |
| Gross Profit | 616.87% | 1,862.81% | 22,364.94% | 9,713.87% | -- |
| SG&A Expenses | 63.68% | 44.72% | 14.81% | 33.70% | 63.94% |
| Depreciation & Amortization | 13,138.56% | 6,991.71% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 129.94% | 74.54% | 22.43% | 24.59% | 34.46% |
| Operating Income | 817.22% | 303.98% | 184.82% | 126.49% | 54.34% |
| Income Before Tax | 876.28% | 325.13% | 194.81% | 133.27% | 58.30% |
| Income Tax Expenses | -834.70% | -3,876.59% | 137.37% | 99.99% | -- |
| Earnings from Continuing Operations | 1,009.40% | 452.12% | 196.32% | 134.20% | 61.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,009.40% | 452.12% | 196.32% | 134.20% | 61.31% |
| EBIT | 817.22% | 303.98% | 184.82% | 126.49% | 54.34% |
| EBITDA | 893.30% | 313.13% | 185.95% | 127.35% | 54.90% |
| EPS Basic | 776.93% | 381.60% | 184.18% | 126.09% | 64.53% |
| Normalized Basic EPS | 719.81% | 283.86% | 182.84% | 125.43% | 61.88% |
| EPS Diluted | 700.24% | 354.59% | 180.44% | 123.55% | 63.74% |
| Normalized Diluted EPS | 646.98% | 269.89% | 179.29% | 123.64% | 61.88% |
| Average Basic Shares Outstanding | 22.29% | 16.97% | 10.67% | 12.17% | 15.76% |
| Average Diluted Shares Outstanding | 36.34% | 24.76% | 14.04% | 13.89% | 15.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |